Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma

Eur J Dermatol. 2007 Mar-Apr;17(2):165-6. doi: 10.1684/ejd.2007.0134. Epub 2007 Mar 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • DNA (Cytosine-5-)-Methyltransferases / antagonists & inhibitors
  • DNA, Viral / analysis
  • Diagnosis, Differential
  • Enzyme Inhibitors / adverse effects
  • Face
  • Female
  • Herpesviridae / genetics
  • Herpesviridae Infections / chemically induced
  • Herpesviridae Infections / diagnosis*
  • Herpesviridae Infections / drug therapy
  • Herpesviridae Infections / pathology
  • Humans
  • Immunocompromised Host
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Myeloablative Agonists / adverse effects
  • Nose
  • Scrotum
  • Skin Diseases, Viral / chemically induced
  • Skin Diseases, Viral / diagnosis*
  • Skin Diseases, Viral / drug therapy
  • Skin Diseases, Viral / pathology
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • DNA, Viral
  • Enzyme Inhibitors
  • Myeloablative Agonists
  • DNA (Cytosine-5-)-Methyltransferases
  • Vidarabine
  • fludarabine